Humana AB (publ) (FRA:47H)
Germany · Delayed Price · Currency is EUR 4.600
-0.160 (-3.36%)
At close: Jan 27, 2026
Humana AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 10,215 | 10,295 | 9,638 | 9,199 | 8,176 | 7,771 |
Other Revenue | - | - | 3 | 4 | 10 | - |
| 10,215 | 10,295 | 9,641 | 9,203 | 8,186 | 7,771 | |
Revenue Growth (YoY) | 2.09% | 6.78% | 4.76% | 12.42% | 5.34% | 4.37% |
Cost of Revenue | 8,046 | 8,025 | 7,530 | 7,253 | 6,333 | 6,039 |
Gross Profit | 2,169 | 2,270 | 2,111 | 1,950 | 1,853 | 1,732 |
Selling, General & Admin | 1,101 | 1,184 | 1,200 | 1,082 | 926 | 913 |
Other Operating Expenses | -25 | -1 | -8 | - | - | 1 |
Operating Expenses | 1,665 | 1,766 | 1,730 | 1,536 | 1,346 | 1,283 |
Operating Income | 504 | 504 | 381 | 414 | 507 | 449 |
Interest Expense | -250 | -284 | -248 | -166 | -138 | -141 |
Interest & Investment Income | 13 | 14 | 17 | 7 | 1 | 1 |
Currency Exchange Gain (Loss) | -1 | -3 | 9 | -3 | -1 | 2 |
Other Non Operating Income (Expenses) | 70 | 1 | - | -3 | -1 | -2 |
EBT Excluding Unusual Items | 336 | 232 | 159 | 249 | 368 | 309 |
Merger & Restructuring Charges | -20 | -20 | - | -1 | -15 | -1 |
Gain (Loss) on Sale of Assets | -13 | -13 | 2 | -9 | - | 26 |
Asset Writedown | - | - | - | -3 | - | -2 |
Other Unusual Items | -4 | -4 | 70 | 38 | 1 | - |
Pretax Income | 299 | 195 | 231 | 274 | 354 | 332 |
Income Tax Expense | 56 | 50 | 53 | 64 | 78 | 70 |
Earnings From Continuing Operations | 243 | 145 | 178 | 210 | 276 | 262 |
Minority Interest in Earnings | -3 | -1 | -2 | - | - | - |
Net Income | 240 | 144 | 176 | 210 | 276 | 262 |
Net Income to Common | 240 | 144 | 176 | 210 | 276 | 262 |
Net Income Growth | 93.55% | -18.18% | -16.19% | -23.91% | 5.34% | 39.36% |
Shares Outstanding (Basic) | 51 | 50 | 48 | 48 | 49 | 53 |
Shares Outstanding (Diluted) | 51 | 50 | 48 | 48 | 49 | 53 |
Shares Change (YoY) | 3.09% | 4.89% | -0.28% | -1.51% | -8.11% | -0.27% |
EPS (Basic) | 4.74 | 2.87 | 3.68 | 4.38 | 5.67 | 4.94 |
EPS (Diluted) | 4.74 | 2.87 | 3.68 | 4.38 | 5.67 | 4.94 |
EPS Growth | 87.75% | -22.00% | -15.95% | -22.74% | 14.64% | 39.74% |
Free Cash Flow | 488 | 570 | 451 | 441 | 572 | 528 |
Free Cash Flow Per Share | 9.63 | 11.36 | 9.43 | 9.20 | 11.75 | 9.96 |
Dividend Per Share | 1.000 | 1.000 | - | - | - | - |
Gross Margin | 21.23% | 22.05% | 21.90% | 21.19% | 22.64% | 22.29% |
Operating Margin | 4.93% | 4.90% | 3.95% | 4.50% | 6.19% | 5.78% |
Profit Margin | 2.35% | 1.40% | 1.83% | 2.28% | 3.37% | 3.37% |
Free Cash Flow Margin | 4.78% | 5.54% | 4.68% | 4.79% | 6.99% | 6.79% |
EBITDA | 221 | 583 | 458 | 478 | 570 | 510 |
EBITDA Margin | 2.16% | 5.66% | 4.75% | 5.19% | 6.96% | 6.56% |
D&A For EBITDA | -283 | 79 | 77 | 64 | 63 | 61 |
EBIT | 504 | 504 | 381 | 414 | 507 | 449 |
EBIT Margin | 4.93% | 4.90% | 3.95% | 4.50% | 6.19% | 5.78% |
Effective Tax Rate | 18.73% | 25.64% | 22.94% | 23.36% | 22.03% | 21.08% |
Revenue as Reported | 10,284 | 10,302 | 9,728 | 9,241 | 8,188 | 7,797 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.